Medicine and Dentistry
Ulcerative Colitis
100%
Neoplasm
89%
Magnetic Resonance Imaging
64%
Patient with Ulcerative Colitis
61%
Disease
61%
Capsule Endoscopy
58%
Esophageal Cancer
49%
Crohn's Disease
49%
Colonoscopy
47%
Esophagectomy
43%
Inflammatory Bowel Disease
41%
Colon
40%
Colitis
39%
Odds Ratio
37%
Stomach Cancer
37%
Endoscopic Submucosal Dissection
36%
Diabetes
36%
Bleeding
36%
Cardiac Muscle Cell
33%
Symptom
33%
Breast Cancer
31%
Malignant Neoplasm
30%
Surgery
30%
Lymph Node Metastasis
30%
COVID-19
30%
Endoscope
28%
Randomized Controlled Trial
28%
Recurrent Disease
26%
Percutaneous Aortic Valve Replacement
26%
Dysplasia
26%
Diagnosis
26%
Esophageal Squamous Cell Carcinoma
25%
Cervical Spine
24%
Angioplasty
24%
Pulmonary Hypertension
23%
Biopsy
23%
Endoscopy
23%
Chronic Thromboembolic Pulmonary Hypertension
22%
Patient with Crohn's Disease
22%
Beta Cell
22%
Echocardiography
22%
Heart Failure
22%
Computer Assisted Tomography
22%
Induced Pluripotent Stem Cell
21%
Adenoma
21%
Clinical Significance
19%
Adverse Event
19%
Chronic Obstructive Pulmonary Disease
19%
Epithelial Cell
18%
Maturity Onset Diabetes of the Young
18%
4-Aminosalicylic Acid
18%
Whiplash Injury
18%
Kidney Function
18%
Biological Marker
17%
Cardiovascular System
17%
Infliximab
17%
Endoscopic Surgery
16%
Quality of Life
16%
Observational Study
16%
Hemodynamic
16%
Lymphocyte
16%
Adenocarcinoma
16%
Epileptic Absence
16%
Chronic Kidney Disease
15%
Centenarians
15%
Upper Gastrointestinal Bleeding
15%
Percutaneous Coronary Intervention
15%
Colorectal Cancer
15%
Cross Sectional Study
14%
Cisplatin
14%
Lymph Node
14%
Combination Therapy
14%
Neoadjuvant Chemotherapy
14%
Endoscopic Mucosal Resection
13%
Metastatic Carcinoma
13%
Retroperitoneal Lymph Node Dissection
13%
C Reactive Protein
13%
Prevalence
13%
Body Mass Index
13%
Sentinel Lymph Node
13%
Drug Therapy
13%
Gastrointestinal Bleeding
13%
Multivariate Analysis
13%
Meibomian Gland
13%
Endocytoscopy
13%
Sentinel Node
13%
Polyp
13%
Hazard Ratio
12%
Epithelioma
12%
Lung Artery Pressure
12%
Volunteer
12%
Prospective Cohort Study
12%
Physical Activity
12%
Morphology
12%
Stem Cell
12%
Cardiovascular Disease
11%
Sarcopenia
11%
Apoplexy
11%
Vasculotropin
11%
Meibomian Gland Dysfunction
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
98%
Disease
64%
Crohn's Disease
63%
Remission
60%
Chemotherapy
51%
Stomach Cancer
42%
Inflammatory Bowel Disease
42%
Breast Cancer
39%
Cisplatin
36%
Malignant Neoplasm
34%
Neoplasm
30%
Heart Failure
30%
Recurrent Disease
26%
Non Insulin Dependent Diabetes Mellitus
26%
Infliximab
23%
Prevalence
21%
Mouse
21%
Chemoradiation Therapy
21%
Diabetes Mellitus
21%
Mineralocorticoid Receptor
20%
Inflammation
20%
Adverse Event
19%
Esophageal Squamous Cell Carcinoma
18%
Cardiovascular Disease
18%
Cohort Study
17%
Mercaptopurine
17%
Combination Therapy
16%
Colitis
16%
Overall Survival
16%
Clinical Trial
15%
Tumor Necrosis Factor
15%
Protein Kinase C
15%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
15%
Symptom
14%
Esophagus Cancer
14%
Gamma Urogastrone
14%
Hemoglobin A1c
13%
Monotherapy
13%
Pancreas Cancer
13%
All Cause Mortality
13%
Ulcer
12%
Intestine Flora
12%
Paclitaxel
12%
Drug Screening
12%
Epidermal Growth Factor Receptor
12%
Pulmonary Hypertension
12%
Aminosalicylic Acid
11%
Chronic Kidney Failure
11%
Randomized Controlled Trial
11%
Ischemia
11%
Biological Marker
11%
Vasculotropin
11%
Chronic Thromboembolic Pulmonary Hypertension
11%
Bilirubin
11%
Musculoskeletal Disease
11%
Hormone Receptor
11%
Immunomodulating Agent
10%
Spine Fracture
10%
Disease Exacerbation
10%
Epidermal Growth Factor Receptor 2
10%
Disease Activity
10%
Glucocorticoid
10%
Low Back Pain
10%
Adenocarcinoma
9%
Progression Free Survival
9%
Cross-Sectional Study
9%
Atrial Fibrillation
9%
Metabolic Disorder
9%
Trastuzumab
9%
Colorectal Cancer
9%
Metastatic Breast Cancer
8%
Gemcitabine
8%
Chronic Obstructive Lung Disease
8%
Bleeding
8%
Phase II Trials
8%
Drug Discovery
8%
Interleukin 6
8%
Ethanol
8%
Dyslipidemia
8%
Tumor Growth
8%
Prospective Cohort Study
8%
Adalimumab
8%
Intervertebral Disk Degeneration
8%
Second-Line Chemotherapy
8%
Metabolic Syndrome X
8%
Prothrombin
8%
First-Line Chemotherapy
8%
Retinopathy
8%
Kidney Disease
8%
Compression Fracture
7%
Epileptic Absence
7%
Cognitive Defect
7%
Anticarcinogen
7%
Antihypertensive Agent
7%
Ovary Cancer
7%
Sorafenib
7%
Cyclophosphamide
7%
Metastatic Colorectal Cancer
7%
Ustekinumab
7%
Fischer 344 Rat
7%
Keyphrases
Ulcerative Colitis
60%
Esophageal Cancer
25%
Ulcerative Colitis Patient
23%
Human Pluripotent Stem Cells (hPSCs)
18%
Japan
17%
Confidence Interval
16%
Esophagectomy
13%
Colitis
12%
Crohn's Disease
12%
Cardiac Reprogramming
12%
COVID-19
11%
5-aminosalicylic Acid (5-ASA)
11%
Osteoporotic Vertebral Compression Fracture
11%
Mineralocorticoid Receptor
11%
Colon Capsule Endoscopy
11%
Dysplasia
11%
Advanced Gastric Cancer
11%
Magnetic Resonance Imaging
10%
Indigo Naturalis
10%
Remission
10%
Clinical Characteristics
9%
Cardiac Regeneration
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Inflammatory Bowel Disease
9%
Cardiomyocytes
9%
Clinical Outcomes
9%
Esophageal Squamous Cell Carcinoma
9%
Induced Pluripotent Stem Cells (iPSCs)
9%
Prognostic Significance
9%
Small Intestine
8%
Diabetes
8%
Superficial Duodenal Epithelial Tumor
8%
Lung
8%
Japanese Population
8%
Fibroblasts
8%
Retrospective Cohort Study
8%
Elderly Patients
8%
Post-esophagectomy
8%
Prospective Randomized Trial
8%
Colon
8%
Odds Ratio
8%
Mesalamine
8%
Colon Cancer Cells
7%
Mayo Endoscopic Subscore
7%
Neoadjuvant Therapy
7%
Whiplash Injury
7%
In Vivo Laser Scanning Confocal Microscopy
7%
Whiplash-associated Disorders
7%
Retinopathy
7%
Lymphocytes
7%
Second-line Treatment
7%
Cell Mass
7%
Corepressor
7%
Sitagliptin
7%
Surveillance Colonoscopy
7%
Mucosal Concentration
7%
Clinical Relapse
7%
Resectability
7%
T Helper 17 (Th17)
7%
Chronic Kidney Disease
7%
Prospective Observational Study
7%
Exposure Radiation
7%
MIS-TLIF
7%
Echocardiography
7%
Pyogenic Granuloma
7%
Negatively Associated
7%
Cisplatin
7%
DNA Methylation Clock
7%
Urinary Shedding
7%
Clinical Application
7%
Stem Cells
7%
Sentinel Lymph Node
7%
CD4+
6%
Video Capsule Endoscopy
6%
Randomized Controlled Trial
6%
Heart Failure
6%
Gastrointestinal Cancer
6%
Adverse Events
6%
Risk Factors
6%
Protein Kinase
6%
Low Back Pain
6%
Capsule Endoscopy
5%
Epithelial Cells
5%
Ulcerative Colitis-associated Colorectal Cancer
5%
Endoscopic Features
5%
Diarrhea
5%
Stomach
5%
Hazard Ratio
5%
Interferon-α (IFN-α)
5%
Endoscopist
5%
Tumor
5%
Endocytoscopy
5%
Endocytoscopy System
5%
Neoadjuvant Chemotherapy
5%
Anastomotic Leakage
5%
Endoscopy
5%
Degenerative Changes
5%
Disease Severity
5%
Early Detection
5%
Esophageal Cancer Surgery
5%